Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma

NCT03803774 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

13

Enrollment

NIH

Sponsor class

Conditions

Locally Recurrent Head and Neck Squamous Cell Carcinoma
Nasopharyngeal Squamous Cell Carcinoma
Sinonasal Squamous Cell Carcinoma

Interventions

PROCEDURE: Biopsy Procedure
DRUG: Birinapant
PROCEDURE: Computed Tomography
RADIATION: Intensity-Modulated Radiation Therapy
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography

Sponsor

National Cancer Institute (NCI)